Study Stopped
Government executive order
A Cognitive Behavioral Therapy Group Intervention to Increase HIV Testing and PrEP Use Among Latinx Sexual Minority Men
1 other identifier
interventional
289
1 country
1
Brief Summary
This study consists of a randomized controlled trial (RCT) of a multi-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP use among Latinx sexual minority men (SMM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv
Started Jan 2020
Longer than P75 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 7, 2020
CompletedFirst Posted
Study publicly available on registry
January 13, 2020
CompletedStudy Start
First participant enrolled
January 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 27, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2024
CompletedResults Posted
Study results publicly available
August 13, 2025
CompletedAugust 13, 2025
November 1, 2023
4.9 years
January 7, 2020
June 20, 2025
July 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
HIV Test at Least Annually
Participants report being tested for HIV at least once in the 12 months after baseline
from baseline to 12-months
Took PrEP in the Past 12 Months
Participants report taking PrEP at any follow-up time-point (within the 12-month follow-up time period)
from baseline to 12-months
Secondary Outcomes (1)
Level of Adaptive Coping
measured at 4-months, 8-months, and 12-months post baseline
Study Arms (2)
CBT Coping Intervention
EXPERIMENTALThe intervention is an 8-session cognitive behavior therapy (CBT) group intervention that aims to improve HIV outcomes by increasing adaptive, effective coping responses to stigma from intersectional identities related to ethnicity, immigration status, sexual minority identity, HIV status, and PrEP among Latinx sexual minority men (SMM). The intervention sessions will address topics such as: understanding and coping with intersectional stigma, multiple identities (e.g., race/ethnicity, sexual orientation), medical mistrust, social support, and structural stigma. Intervention groups will be led by a trained facilitator (with expertise in group therapy with Latinx SMM) and a trained peer co-facilitator matched in identities with participants (Latinx SMM).
Control
NO INTERVENTIONParticipants who are randomized to the control condition will be referred to the standard of care program at Bienestar, which includes an ongoing weekly open wellness-oriented support group available to all clients.
Interventions
A cognitive behavior therapy group intervention for HIV-negative Latinx sexual minority men aimed at increasing HIV testing and prevention strategies.
Eligibility Criteria
You may qualify if:
- at least 18 years-old
- biologically male at birth
- identify as male
- identify as Latino
- is an immigrant
- report having sex with men in the past 12 months
- report HIV-negative or unknown serostatus
- anticipate being available for the next 12 months to attend study visits
- able to interact and communicate in spoken Spanish or English.
You may not qualify if:
- HIV-positive
- cisgender women
- transgender women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RANDlead
- Bienestar Human Services, Inc.collaborator
Study Sites (1)
Bienestar Human Services, Inc
Los Angeles, California, 90022, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Objective HIV testing dates and PrEP prescription data were collected (e.g., from medical records), but the US federal government (NIH) terminated the grant prematurely on March 20, 2025 before these data could be processed. These data were not fully cleaned or tabulated, and thus were not analyzed as an outcome and cannot be entered at baseline: The number of records is unknown and therefore not reported here. Thus, the primary outcomes are reported based on self-reported survey responses.
Results Point of Contact
- Title
- Laura Bogart, PhD
- Organization
- RAND
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Bogart, PhD
RAND
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcomes assessor does not randomize participant until after the baseline assessment
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 7, 2020
First Posted
January 13, 2020
Study Start
January 20, 2020
Primary Completion
November 27, 2024
Study Completion
November 27, 2024
Last Updated
August 13, 2025
Results First Posted
August 13, 2025
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share